Nitric oxide and the neurotoxic effects of methamphetamine and 3,4- methylenedioxymethamphetamine

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 2, 1997, Pages 941-947

  Taraska, Terri ^a   Finnegan, Kevin T ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; DOPAMINE; ISOSORBIDE DINITRATE; METHAMPHETAMINE; N(G) METHYLARGININE; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLON; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG ANTAGONISM; HYPERTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SUBCUTANEOUS DRUG ADMINISTRATION; TEMPERATURE;

3,4-DIHYDROXYPHENYLACETIC ACID; ANALYSIS OF VARIANCE; ANIMALS; BODY TEMPERATURE; BRAIN; CATECHOLAMINES; CORPUS STRIATUM; DOPAMINE; FRONTAL LOBE; HIPPOCAMPUS; HOMOVANILLIC ACID; HYDROXYINDOLEACETIC ACID; ISOSORBIDE DINITRATE; MALE; METHAMPHETAMINE; MICE; MICE, INBRED STRAINS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROTOXINS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN;

EID: 0030942170     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. ABEKAWA, T., OHMORI, T. AND KOYAMA, T.: Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens. Brain Res. 643: 276-281, 1994.
2. ADACHI, K., KENNEDY, C., WANG, F., TAKAHASHI, S., MELZER, P. AND SOKOLOFF, L.: Effect of nitric oxide synthase inhibitors on increases in local cerebral blood flow induced by whisker stroking. J. Cereb. Blood Flow Metab. 13: suppl. 1, S152, 1993.
3. ALBERS, D. S. AND SONSALLA, P. K.: Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: Pharmacological profile of protective and nonprotective agents. J. Pharmacol. Exp. Ther. 275: 1104-1114, 1995.
4. ASHWAL, S., COLE, D. J., OSBORNE, T. N. AND PEARCE, W. J.: Low dose L-NAME reduces infarct volume in the rat MCAO/reperfusion model. J. Neurosurg. Anesth. 5: 241-249, 1993.
5. BOWYER, J. F., DAVIES, D. L., SCHMUED, L., BROENING, H. W., NEWPORT, G. D., SLIKKER, W., JR. AND HOLSON, R. R.: Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J. Pharmacol. Exp. Ther. 268: 1571-1580, 1994.
6. BOWYER, J. F., GOUGH, B., SLIKKER, W., JR., LIFE, G. W., NEWPORT, G. D. AND HOLSON, R. R.: Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats. Pharma col. Biochem. Behav. 44: 87-98, 1993.
7. BREDT, D. S. AND SNYDER, S. H.: Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. U.S.A. 86: 9030-9033, 1989.
8. BREDT, D. S. AND SNYDER, S. H.: Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. U.S.A. 87: 682-685, 1990.
9. BUISSON, A., PLOTKINE, M. AND BOULU, R. G.: The neuroprotective effect of a nitric oxide inhibitor in a rat model of focal ischemia. Br. J. Pharmacol, 106: 766-767, 1992.
10. CHOI, D. W.: Glutamate neurotoxicity and diseases of the nervous system. Neuron 1: 623-634, 1988.
11. COYLE, J. T. AND PUTTFARCKEN, P.: Oxidative stress, glutamate, and neurodegenerative disorders. Science (Wash. DC) 262: 689-695, 1993.
12. DAWSON, V. L., DAWSON, T. M., LONDON, E. D., BREDT, D. S. AND SNYDER, S. H.: Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. U.S.A. 88: 6368-6371, 1991.
13. DIMMELER, S., LOTTSPEICH, F. AND BRUNE, B.: Nitric oxide causes ADP-ribosylation and inhibition of glyceraldehyde-3-phosphate dehydrogenase J. Biol. Chem. 267: 16771-16774, 1992.
14. g-nitroarginine in brain in vitro and in vivo. Biochem. Biophys. Res. Commun. 176: 1136-1141, 1991.
15. ELLISON, G. M., EISON, M. S., HABERMAN, H. S. AND DANIEL, F.: Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration. Science (Wash. DC) 201: 276-278, 1978.
16. FARFEL, G. M. AND SEIDEN, L. S.: Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX. J. Pharmacol. Exp. Ther. 272: 860-867, 1995.
17. FINNEGAN, K. T., DELANNEY, L. E., IRWIN, I., RICAURTE, G. A. AND LANGSTON, J. W.: The amine-depleting effects of 5,7-dihydroxytryptamine (5,7-DHT) in C57BL/6 mice do not increase with age. Brain Res. 496: 251-256, 1989.
18. FINNEGAN, K. T., KERR, J. T. AND LANGSTON, J. W.: Dextromethorphan protects against the neurotoxic effects of p-chloroamphetamine in rats. Brain Res. 558: 109-111, 1991.
19. FINNEGAN, K. T. AND SCHUSTER, C. R.: The methylenedioxyamphetamines: Pharmacological, behavioral and neurotoxic effects. In Clandestinely Produced Drugs, Analogues and Precursors, ed. by M. Klein, F. Sapienza and H. McClain, Jr., pp. 195-206, United States Department of Justice, Washington, DC, 1989.
20. FINNEGAN, K. T., SKRATT, J. J., IRWIN, I. AND LANGSTON, J. W.: The N-methyl-d-aspartate (NMDA) receptor antagonist, dextrorphan, prevents the neurotoxic effects of MDMA in rats. Neurosci. Lett. 105: 300-306, 1990.
21. GARTHWAITE, G. AND GARTHWAITE, J.: Nitric oxide does not mediate acute glutamate neurotoxicity, nor is it neuroprotective, in rat brain slices. Neuropharmacology 33: 1431-1438, 1994.
22. GARTHWAITE, J., CHARLES, S. L. AND CHESS-WILLIAMS, R.: Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature (Lond.) 336: 385-388, 1988.
23. GARTHWAITE, J., GARTHWAITE, G., PALMER, R. M. J. AND MONCADA, S.: NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur. J. Pharmacol. 172: 413-416, 1989.
24. GIBB, J. W., JOHNSON, M. AND HANSON, G. R.: Neurochemical basis of neurotoxicity. Neurotoxicology 11: 317-321, 1990.
25. IADECOLA, C., PELLIGRINO, D. A., MOSKOWITZ, M. A. AND LASSEN, N. A.: Nitric oxide synthase inhibition and cerebrovascular regulation. J. Cereb. Blood Flow Metab. 14: 175-192, 1994.
26. KADER, A., FRANZZINE, V. I., SOLOMON, R. A. AND TRIFILETTI, R. R.: Nitric oxide production during focal cerebral ischemia in rats. Stroke 24: 1709-1716, 1993.
27. KNOWLES, R. G., PALACIOS, M., PALMER, R. M. J. AND MONCADA, S.: Formation of nitric oxide from 1-arginine in the central nervous system: A transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Natl. Acad. Sci. U.S.A. 86: 5159-5162, 1989.
28. KULUZ, J. W., PRADO, R. J., SCHEIN, C. L. AND WATSON, B. D.: The effect of nitric oxide synthase inhibition on infarct volume following reversible focal cerebral ischemia in conscious rats. Stroke 24: 2023-2029, 1993.
29. MALINSKI, T., BAILEY, F., ZHANG, Z. G. AND CHOPP, M.: Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery, occlusion. J. Cereb. Blood Flow Metab. 13: 355-358, 1993.
30. MILLER, D. B. AND O'CALLAGHAN, J. P.: The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine. Mol. Neurobiol. 11: 177-192, 1995.
31. MOLLIVER, M. E., BERGER, U. V., MAMOUNAS, L. A., MOLLIVER, D. C., O'HEARN, E. AND WILSON, M. A.: Neurotoxicity of MDMA and related compounds: Anatomic studies. Ann. N.Y. Acad. Sci. 600: 649-661, 1990.
32. MONCADA, S., PALMER, R. M. J. AND HIGGS, E. A.: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43: 109-142, 1991.
33. NAGAFUJI, T., MATSUI, T., KOIDE, T. AND ASANO, T.: Blockade of nitric oxide formation by N-omega-nitro-1-arginine mitigates ischemic brain edema and subsequent cerebral infarction in rats. Neurosci. Lett. 147: 159-162, 1992.
34. NASH, J. F. AND YAMAMOTO, B. K.: Methamphetamine neurotoxicity and striatal glutamate release: Comparison to 3,4-methylenedioxymethamphetamine. Brain Res. 581: 237-243, 1992.
35. NASH, J. F. AND YAMAMOTO, B. K.: Effect of d-amphetamine on the extracellular concentrations of glutamate and dopamine in iprindole-treated rats. Brain Res. 627: 1-8, 1993.
36. NATHAN, C.: Nitric oxide as a secretory product of mammalian cells. FASEB J. 6: 3051-3064, 1992.
37. NOWICKI, J. P., DUVAL, D., POIGNET, H. AND SCATTON, B.: Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. Eur. J. Pharmacol. 204: 339-340, 1991.
38. RADI, R., BECKMAN, J. S., BUSH, K. M. AND FREEMAN, B. A.: Peroxynitrite oxidation of sulfhydryls. J. Biol. Chem. 266: 4244-4250, 1991.
39. RlCAURTE, G. A., GUILLERY, R. W., SEIDEN, L. S., SCHUSTER, C. R. AND MOORE, R. Y.: Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res. 235: 93-103, 1982.
40. SATO, S., TOMINAGA, T., OHNISHI, T. AND OHNISHI, S. T.: EPR spin-trapping study of nitric oxide formation during bilateral carotid occlusion in the rat. Biochim. Biophys. Acta 1181: 195-197, 1993.
41. 2 receptors. Brain Res. 529: 85-90, 1990.
42. SCHMIDT, C. J., RITTER, J. K., SONSALLA, P. K., HANSON, G. R. AND GIBB, J. W.: Role of dopamine in the neurotoxic effects of methamphetamine. J. Pharmacol. Exp. Ther. 233: 539-544, 1985.
43. SEIDEN, L. S. AND RICAURTE, G. A.: Neurotoxicity of methamphetamine and related drugs. In Psychopharmacology: A Third Generation of Progress, ed. by H. Y. Meltzer, pp. 359-366, Raven Press, New York, 1987.
44. SONSALLA, P. K., NICKLAS, W. J. AND HEIKKILA, R. E.: Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science (Wash. DC) 243: 398-400, 1989.
45. SONSALLA, P. K., RIORDAN, D. E. AND HEIKKILA, R. E.: Competitive and noncompetitive antagonists at N-methyl-d-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice. J. Pharmacol. Exp. Ther. 256: 506-512, 1991.
46. STADLER. J., BILLIAR, T. R., CURRAN, R. D., STUEHR, D. J., OCHOA, J. B. AND SIMMONS, R. L.: Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am. J. Physiol. 260: C910-C916, 1991.
47. STONE, D. M., HANSON, G. R. AND GIBB, J. W.: Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats. Neuropharmacology 26: 1657-1661, 1987.
48. STONE, D. M., JOHNSON, M., HANSON, G. R. AND GIBB, J. W.: Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther. 247: 79-87, 1988.
49. TANAKA, K., GOTOH, F., GOMI, S., TAKASHIMA, S., MIHARA, B., SHIRAI, T., NOGAWA, S. AND NAGATA, E.: Inhibition of nitric oxide synthesis induces a significant reduction in local cerebral blood flow in the rat. Neurosci. Lett. 127: 129-132, 1991.
50. WINK, D. A., KASPRZAK, K. S., MARAGOS, C. M., ELESPURU, R. K., MISRA, M., DUNAMS, T. M., CEBULA, T. A., KOCH, W. H., ANDREWS, A. W., ALLEN, J. S. AND KEEPER, L. K.: DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science (Wash. DC) 254: 1001-1003, 1991.
51. YAMAMOTO, S., GOLANOV, E. V., BERGER, S. B. AND REIS, D. J.: Inhibition of nitric oxide synthesis increases focal ischemic infarction in rat. J. Cereb. Blood Flow Metab. 12: 717-726, 1992.
52. ZHANG, J., DAWSON, V. L., DAWSON, T. M. AND SNYDER, S. H.: Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science (Lond.) 263: 687-689, 1994.